Selank and GABA: Findings from the IMR-32 Cell Study
A detailed review of the IMR-32 neuroblastoma cell study examining Selank alone and in combination with GABA, focusing on gene expression changes in the GABAergic system. Evidence is limited to in vitro findings and does not imply clinical effects.
2026-09-29Read resource